Evidence map›Paper›PMID 35888539›Full record

ArticleMaterials (Basel, Switzerland)2022

Effect of Aggregate Type on Properties of Ultra-High-Strength Concrete.

Anna Szcześniak, Jarosław Siwiński, Adam Stolarski

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna SzcześniakFaculty of Civil Engineering and Geodesy, Military University of Technology, 2 Gen. S. Kaliskiego Street, 00-908 Warsaw, Poland.ORCID 0000-0002-3936-9847
Jarosław SiwińskiFaculty of Civil Engineering and Geodesy, Military University of Technology, 2 Gen. S. Kaliskiego Street, 00-908 Warsaw, Poland.ORCID 0000-0003-4805-166X
Adam StolarskiFaculty of Civil Engineering and Geodesy, Military University of Technology, 2 Gen. S. Kaliskiego Street, 00-908 Warsaw, Poland.ORCID 0000-0002-4754-3067

Funding

Faculty of Civil Engineering and Geodesy of Military University of Technology 2/DPH/2020
6 · The paper itself

Abstract

In this work, we present an analysis of natural fine aggregates' influence on the properties of ultra-high-strength concrete. The reference concrete mix was made of natural sand with the addition of fly ash and microsilica. It was assumed to obtain concrete with a very high strength without the addition of fibers and without special curing conditions, ensuring the required workability of the concrete mix corresponding to the consistency of class S3. The reference concrete mix was modified by replacing sand with granite and basalt aggregate in the same fractions. Five series of concrete mixes made with CEM I 52.5R cement were tested. Experimental investigations were carried out regarding the consistency of the concrete mix, the compressive strength, the flexural strength and the water absorption by hardened concrete. A comparative analysis of the obtained results indicated significant improvement in the concrete strength after the use of basalt aggregate. The strength of the concrete series based on basalt aggregate, BC1, allowed it to be classified as ultra-high-performance concrete. Concrete based on sand, SC1, was characterized by the lowest compressive and flexural strength but obtained the best workability of the mix and the lowest water absorption. The results presented in the paper, show a significant influence of the type of aggregate used on the mechanical and physical properties of ultra-high strength concrete.

Indexed as

mechanical propertiesnatural fine aggregatesultra-high-strength concrete

Identifiers

PMID35888539
PMCPMC9320686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.